A site where you can find recommended contractors for non-clinical testing｜effical

The company is contracted to perform a variety of pharmacological studies for cardiovascular, allergic, anti-fatigue, and other medicinal effects. It is a model for pathological conditions.Possesses a unique drug evaluation system using genetically modified animalsThe following are some of the features of this product.

The company offers a wide range of services from various safety studies, pharmacology studies, and pharmacokinetic studies for regulatory approval applications, including JSTP and JCVP certified pathologists and JSOT certified toxicologists.Strengths of having experts on staffPharmacodynamics(PD) Studies

Drug discovery projects, from consultation on drug discovery strategies to the execution of individual trialsSupport mainly for lead compound optimization stageWe are a company that has been engaged in the development of new products and services. We have a team of highly experienced engineers who have been cultivated through many contracting projects.

CMIC Holdings proposes services that match your needs, as a contract research facility that is GLP compliant and fully AAALAC certified,Can support various evaluation studies and new drug development plans through to applicationThis is a strength of the company.

The company conducts non-clinical studies necessary for the development of pharmaceuticals, medical devices, regenerative medicine products, and chemical substances in accordance with the latest regulations.We also conduct specific efficacy studies in the CNS and ophthalmology areas.This is a strength of the company.

We provide high quality safety, efficacy, pharmacology, and pharmacokinetic studies based on various guidelines.Support for numerous studies ranging from Phase I clinical trials to post-marketing surveillanceThe strength of the company is its pursuit of higher quality and safety.

We are a company that handles radiopharmaceuticals, other pharmaceuticals, and regenerative medicine products. We conduct a wide variety of quality tests, and we have established quality control standards for our products.Features radiopharmaceuticals that have passed strict criteriaPharmacodynamics(PD) Studies

The company conducts studies in various disease areas with a focus on pharmacodynamic studies.We can also handle evaluation system start-up tests for Procoats without any experience in implementation.Pharmacodynamics(PD) Studies

The company's strengths lie in its trust and track record backed by 40 years of history and the technologies accumulated at its GLP facilities. The company is characterized by its wide range of services, from small animal studies to non-clinical studies using large animals.

High qualityStrengths of using PXB mice, a human hepatocyte chimera mouseThe company's strength lies in non-clinical studies utilizing PXB mice (mice in which more than 70% of the liver has been replaced by human hepatocytes).

A company that develops many disease models mainly by contracting pharmacological studies, and as a CRO, conducts mainly safety studies and contract pharmacological studies using miniature pigs.

The Compound Safety Laboratory has over 50 years of experience in non-clinical testing since its establishment and is a GLP-compliant facility for all pharmaceuticals, medical devices, and regenerative medicine.

The company specializes in pharmacokinetic studies and synthesis contract services, including in vivo and in vitro studies, drug discovery and development studies, and synthesis contract services.

A company that provides research and development support in various fields including biotechnology-related fields. As an agency, we are a company that is contracted to conduct "pharmacodynamic studies", "toxicity studies", and "pharmacokinetic studies" (in vitro/vivo).

The company provides a wide range of testing services, including blood and urine testing, toxicity testing, and safety pharmacology testing. As a distributor, the company provides total support for genome editing mouse creation and breeding using CRISPR/Cas9, and phenotypic analysis.

We are a company that also handles non-clinical (in vivo and in vitro) functional and safety evaluations, identification of involved ingredients, and qualitative and quantitative methods. As a distributor, we partner with facilities specializing in non-clinical studies to conduct more challenging studies.

We are a company engaged in contract research business focusing on non-clinical pharmacokinetic studies using radiolabeled compounds. As an agency, our strength is total solutions combining safety and pharmacokinetic studies.

We are a company engaged in contract research business with a focus on non-clinical pharmacokinetic studies using radiolabeled compounds. As an agency, we conduct licensed studies on genetically engineered mice that have been established and analyzed at universities and research institutes.

We are the exclusive Japanese agent for contract clinical safety testing. In cooperation with BIOTOXTECH in Korea, we handle a variety of tests in each field, including not only cosmetics, but also food, chemicals, agrochemicals, and pharmaceuticals.

We provide high-quality pharmacodynamic and pharmacokinetic studies based on various guidelines. We also work with partner companies to support regulatory submissions for new biomarkers that are essential for drug development.

We have extensive experience in the measurement of drug concentrations in biological samples in non-clinical and clinical studies, and we perform various concentration measurements in drug development under the GLP and reliability standards system.

The company works with laboratory animal manufacturers to provide contract animal care and management before, during, and after animal testing, as well as to supply and support testing of the Microminipig®, the world's smallest class of domestic micro pigs.

As one of the few veterinary CROs in Japan, we are one of the few companies that conducts many contract studies. We conduct a variety of tests to contribute to the production and processing process of food products and to the improvement of food safety.

As a CRO, we have successfully completed INDs in the U.S. and Taiwan and support the development of synthetic and biopharmaceuticals from discovery, submission, and production to clinical trials. The company provides biological testing services.

We are a company that is contracted to perform safety testing of pharmaceuticals, medical devices, health foods, and other products. We are capable of conducting tests recommended by international standards such as ISO10993, FDA, ASTM, OECD, etc. as well as the guidelines of the Ministry of Health, Labor and Welfare.

We are a drug discovery support company specializing in non-clinical studies mainly using non-human primates (NHPs). The company's strength lies in its ability to effectively conduct pharmacological studies in various areas where new drugs are desired, such as cerebral infarction, central nervous system diseases, and intractable diseases.

Takara Bio, with its extensive experience in non-clinical testing, has the advantage of GLP safety testing being conducted at facilities that have been approved for GLP compliance for regenerative medicine products, and total support in conjunction with regenerative medicine product manufacturing.

We provide high-quality, guideline-based safety, efficacy, pharmacology, and pharmacokinetic studies. We also offer a variety of analytical services and in vivo studies to support non-clinical safety, efficacy, and pharmacology studies.

Explicyte is a preclinical and translational research CRO specializing in cancer immunotherapy research and development. We support drug efficacy/pharmacological evaluation and biomarker discovery through immune-related assays, animal model studies, and human sample analysis. We support efficacy and safety validation of cancer immunotherapy through our consistent system from in vitro to in vivo studies.

We provide high-quality drug efficacy evaluation studies, mechanism-of-action elucidation, and target exploration studies based on our proprietary PCLS technology. Our strength lies in our ability to reproduce pathological conditions with high precision that preserves the structure of living human tissues. We also support the evaluation of drug efficacy in non-clinical studies in fibrosis diseases of the liver, kidney, and lungs, and mechanism analysis using genetic analysis and other methods to obtain data with high clinical predictive value.

Specializing in metabolic and fibrosis areas such as obesity, diabetes, and MASH, we provide high-quality pharmacopharmacological studies and comprehensive analytical services for elucidating mechanisms of action (MoA). In addition to our proprietary models with high clinical predictive power, we also have strengths in AI pathology analysis and whole brain 3D imaging technology, and can provide strong backup for our clients' drug discovery research by handling advanced drug efficacy evaluation and mechanism identification in non-clinical settings.

We provide high-precision gene editing using proprietary technologies such as Cas-CLOVER, as well as drug efficacy/pharmacology and toxicity studies using immunodeficient rats, SRG Rats. We are strong in acquiring highly predictive clinical data due to our human-like metabolic functions and abundant sample volume, and we can flexibly respond to complex non-clinical studies in the field of oncology and the creation of custom models to meet our clients' needs.

We provide drug pharmacology studies utilizing our own high-quality induction kits, as well as ex vivo T cell function analysis and detailed histopathological evaluation. We are particularly strong in inflammation and autoimmune disease models such as multiple sclerosis (EAE) and rheumatoid arthritis (CIA), and can flexibly respond to diverse research needs in the non-clinical stage, from validation of drug targets to clarification of mechanisms of action (MoA).

We provide high-quality pharmacology and pharmacokinetics (PK) studies based on advanced image analysis technology, and are strong in non-invasive evaluation using OCT and micro-CT, enabling detailed quantitative analysis in the skin and bone areas. We also provide flexible customization of test systems according to research phases while taking animal welfare into consideration, and strongly support the acquisition of highly reliable data in drug discovery research.

We are a global integrated CRDMO with research sites in India and France. We provide a full range of services from target identification in the early stages of drug discovery, to non-clinical pharmacology, DMPK and toxicology studies, to scale-up manufacturing of active pharmaceutical ingredients (APIs).

We are a global full-service contract research organization (CRO), providing integrated toxicology, DMPK, and safety evaluations required for IND and CTA approvals. Our services range from small molecules to modalities such as cell and gene therapy (CAR-T).

A not-for-profit, non-clinical CRO based in New Mexico with strengths in respiratory diseases, infectious diseases, and gene therapy, the company has been in business for nearly 80 years, since 1947, and owns a large GLP-compliant facility, ABSL-3, and other equipment.

We are a contract research organization (CRO) for non-clinical studies with deep expertise in the fields of neurological diseases, pain, and inflammation. We provide flexible study programs from the early stages of drug discovery to the transition to clinical trials, and support the acquisition of highly accurate data.

Non-clinical CRO with screening platforms theraTRACE and opioidTRACE, with over 150 validated animal models ranging from metabolic and neurological diseases to pain and oncology.